Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New cells from old

N Scolding1

  • 1Institute of Clinical Neurosciences, University of Bristol, Frenchay Hospital, UK. N.J.Scolding@bristol.ac.uk

Lancet (London, England)
|February 24, 2001
PubMed
Summary

No abstract available in PubMed .

Keywords:
Biomedical and Behavioral ResearchGenetics and ReproductionLegal Approach

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021
Same author

Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.

Neuropathology and applied neurobiology·2016
Same author

Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2013
Same author

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

Neurology·2011
Same author

The relationship between relapse, impairment and disability in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2011
Same author

Adult stem cells and multiple sclerosis.

Cell proliferation·2011
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles